Obesity, voracity, and short stature:: the impact of glutamate on the regulation of appetite

被引:80
|
作者
Hermanussen, M
García, AP
Sunder, M
Voigt, M
Salazar, V
Tresguerres, JAF
机构
[1] Univ Complutense, Dept Physiol, Sch Med, Madrid, Spain
[2] Univ Munich, Volkswirtschaftliches Inst, Munich, Germany
[3] Univ Greifswald, Zentrum Kinder & Jugendmed, Dept Neonatol & Paediat Intens Care, Greifswald, Germany
关键词
obesity; voracity; short stature; glutamate; arcuate nucleus;
D O I
10.1038/sj.ejcn.1602263
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: World-wide obesity has risen to alarming levels. We present experimental support for a new and very challenging hypothesis linking obesity, voracity, and growth hormone (GH) deficiency, to the consumption of elevated amounts of the amino-acid glutamate (GLU). Supraphysiological doses of GLU are toxic for neuronal cells. Methods: Human data were obtained from 807 592 German conscripts born between 1974 and 1978, and from 1 432 368 women of the German birth statistics (deutsche Perinatalerhebung) 1995 - 1997. The effects of orally administered monosodium glutamate (MSG) were investigated in 30 pregnant Wistar rats and their offspring. Pregnant animals either received no extra MSG, or 2.5 g MSG, or 5 g MSG per day, up to the end of the weaning period. In all, 2.5 g, respectively 5 g, MSG accounted for some 10%, respectively 20%, of dry weight of the average daily food ration. After weaning, MSG feeding was continued in the offspring. Findings: Morbid obesity associates with short stature. Average stature of conscripts progressively declines when body mass index increases above 38 kg/m(2). Also morbidly obese young women are shorter than average though to a lesser extent than conscripts. Oral administration of MSG to pregnant rats affects birth weight of the offspring. Maternal feeding with 5 g MSG per day results in severe birth weight reduction (P<0.01). Weight increments remain subnormal when MSG feeding to the mothers is maintained during weaning (P<0.01). GH serum levels are affected in animals that received MSG during prenatal life via maternal feeding. Animals that are kept on high MSG diet ( 5 g MSG per day) continue to show serum GH levels that are as low or even lower than those of MSG injected animals (P<0.05), both at day 30 and at day 90 of life. Animals that were kept on medium MSG diet ( 2.5 g MSG per day) showed low serum GH levels at day 30 of life (P<0.01), but seemed to partially recover before day 90. Almost identical results were observed in IGF-1 serum levels. Oral MSG resulted in dose dependent voracity. The animals fed 5 g MSG per day increased water uptake by threefold (P<0.01), and food uptake by almost two-fold (P<0.01). The influence of MSG is in general more marked in males than in females. Interpretation: GLU is a widely used nutritional substance that potentially exhibits significant neuronal toxicity. Voracity, and impaired GH secretion are the two major characteristics of parenterally administered GLU-induced neuronal damage. GLU maintains its toxicity in animals even when administered orally. Males appear to be more sensitive than females. The present study for the first time demonstrates, that a widely used nutritional monosubstance - the flavouring agent MSG - at concentrations that only slightly surpass those found in everyday human food, exhibits significant potential for damaging the hypothalamic regulation of appetite, and thereby determines the propensity of world-wide obesity. We suggest to reconsider the recommended daily allowances of amino acids and nutritional protein, and to abstain from the popular protein-rich diets, and particularly from adding the flavouring agents MSG.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [1] Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite
    M Hermanussen
    A P García
    M Sunder
    M Voigt
    V Salazar
    J A F Tresguerres
    European Journal of Clinical Nutrition, 2006, 60 : 25 - 31
  • [2] Obesity and central regulation of appetite
    Nakazato, Masamitsu
    ENDOCRINE JOURNAL, 2010, 57 : S199 - S199
  • [3] OBESITY AND SHORT STATURE IN CHILDREN WITH MYELOMENINGOCELE
    HAYESALL.MC
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 1972, 14 : 59 - 64
  • [4] Morbid obesity is associated with short stature
    Hermanussen, M
    Sunder, M
    Voigt, M
    Tresguerres, JAF
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2005, 18 (07): : 647 - 650
  • [5] NEUROPEPTIDES, APPETITE REGULATION, AND HUMAN OBESITY
    WILBER, JF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (02): : 257 - 259
  • [6] APPETITE REGULATION, OBESITY, AND EATING DISORDERS
    KUSHNER, R
    PENDARVIS, L
    CURRENT OPINION IN GASTROENTEROLOGY, 1995, 11 (02) : 179 - 185
  • [7] Appetite regulation and seasonality: implications for obesity
    Adam, CL
    Mercer, JG
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2004, 63 (03) : 413 - 419
  • [8] Obesity among Egyptian Adults with Short Stature
    Ibrahim, Sahar A.
    Samy, Maysa A.
    Saleh, Azza O. L.
    Ahmed, Gulsen S.
    Matter, May K.
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2010, 5 (02): : 98 - 104
  • [9] Short Stature and Obesity in Women Living in Slums
    Alves, Joao G.
    Pinto, Renato A.
    Falcao, Romero W.
    JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, 2011, 2 : S83 - S83
  • [10] Role of PYY in appetite regulation during obesity
    le Roux, C. W.
    Shurey, S.
    Vincent, R. P.
    Ghatei, M. A.
    Bloom, S. R.
    JOURNAL OF ANIMAL SCIENCE, 2004, 82 : 80 - 81